AKT1 and prostate cancer: These findings indicate that the CaMKK2 signaling pathway may also be associated with prostatic cancer cell survival, in manner similar to that of the CaMKK1/Akt pathway, which has been suggested to play a role in cell survival in LNCaP prostatic cancer cells [36].